Company's New cGMP Manufacturing Facility in Shanghai Zhangjiang Officially Commences Operations

To meet the growing demands for clinical and commercial manufacturing, the company's advanced cGMP

Enters Strategic Collaboration with Pharma Giant Huinuo Pharma to Co-Develop Next-Generation Gene Editors

We are pleased to announce a strategic collaboration and license agreement with global pharmaceutical leader Huinuo Pharma

Our Novel AI-Driven Platform Successfully Unlocks \"Undruggable\" Targets, Boosting Drug Discovery Efficiency by 100-Fold

Our biotechnology company today announced a breakthrough in its proprietary AI-powered drug discovery platform, \"PharmaCloud.\" By leveraging deep learning and molecular dynamics simulations

CAR-T Therapy for Solid Tumors Demonstrates Positive Topline Data in Phase I Clinical Trial

The company released positive topline results from the Phase I clinical trial of its leading candidate, CTA-101, a CAR-T therapy designed for solid tumors.